Abstract
First-line therapy for severe asthma in children is inhaled short-acting beta-agonists and intravenous corticosteroids. But if this approach doesn't work, then what? Intravenous beta-agonists such as terbutaline were once recommended but are no longer, because of concern about potential cardiac toxicity. In a prospective study, researchers used cardiac troponin T (TnT), a specific …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
